Abstract
Although lysine methylation is classically known to regulate histone function, its role in modulating antiviral restriction factor activity remains uncharacterized. Interferon-induced transmembrane protein 3 (IFITM3) was found monomethylated on its lysine 88 residue (IFITM3-K88me1) to reduce its antiviral activity, mediated by the lysine methyltransferase SET7. Vesicular stomatitis virus and influenza A virus infection increased IFITM3-K88me1 levels by promoting the interaction between IFITM3 and SET7, suggesting that this pathway could be hijacked to support infection; conversely, IFN-α reduced IFITM3-K88me1 levels. These findings may have important implications in the design of therapeutics targeting protein methylation against infectious diseases.
Highlights
Interferon-induced transmembrane protein 3 (IFITM3) is a general antiviral host restriction factor against RNA viruses
The interaction between IFITM3 and SET7 was confirmed by reciprocal co-immunoprecipitation using HA-IFITM3 or FLAG-SET7 independently as bait (Fig. 1D) and by in vitro GST pulldown with recombinant GST-IFITM3 and His-SET7 proteins that were purified from E. coli (Fig. 1E)
Other lysine methyltransferases were not screened for their interaction with IFITM3, we believe that the methyltransferase
Summary
IFITM3 is a general antiviral host restriction factor against RNA viruses. Results: SET7-mediated monomethylation of IFITM3 at Lys-88 negatively affected its antiviral activity toward vesicular stomatitis virus (VSV) and influenza A virus (IAV) infection. Lysine methylation is classically known to regulate histone function, its role in modulating antiviral restriction factor activity remains uncharacterized. Vesicular stomatitis virus and influenza A virus infection increased IFITM3-K88me levels by promoting the interaction between IFITM3 and SET7, suggesting that this pathway could be hijacked to support infection; IFN-␣ reduced IFITM3-K88me levels These findings may have important implications in the design of therapeutics targeting protein methylation against infectious diseases. It is appreciated that lysine methylation may affect non-histone proteins, including viral effectors (19 –22), there have yet to be any reports that indicate a role for lysine methylation in controlling the activity of antiviral host restriction factors, and a PTM enzyme has not been identified that targets IFITM3. We focused on uncovering the role of monomethylation on IFITM3 function and finding the PTM enzyme responsible for this process
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have